Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)

A Necchi, H Nishiyama, N Matsubara, JL Lee, DP Petrylak, Ronald de Wit, A Drakaki, AM Liepa, HZ Mao, K Bell-McGuinn, T Powles

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
18 Downloads (Pure)
Original languageEnglish
Article number181
JournalBMC Urology
Volume20
Issue number1
DOIs
Publication statusPublished - 2020

Research programs

  • EMC OR-01

Cite this